Cite

HARVARD Citation

    Nathan, S. et al. (2019). Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. Lancet. 7 (9), pp. 780-790. [Online]. 
  
Back to record